Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
Presentation Icons
Event Add-on
In Person Only
Off-site Event
Location: Marriott Marquis
Back
Main Session
Favorite
Facebook
Tweet
EDU 19 - Is Consolidation Radiotherapy Still Needed for Lymphoma in 2024? Reappraisal in Light of Recent Trials Results
Do We Still Need DA-EPOCH after IELSG-37 and the Results of PET-Guided RT for PMBCL?
Monday, September 30, 2024
8:02 AM – 8:17 AM
ET
Location: Room 143
Speaker(s)
Umberto Ricardi, MD, PhD
University of Torino
Turin , Italy, Italy
Learning Objectives:
Explain the data supporting combined modality treatment in early Hodgkin lymphoma and quantify the benefit for individual patients.
Determine which patients with Primary Mediastinal B-cell Lymphoma benefit from consolidation radiotherapy.
Assess disease and patient factors to select patients for consolidation RT in DLBCL.